Related Experiment Video
Updated: Dec 8, 2025

Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion
Published on: June 15, 2019
The CXCL12/CXCR4/ACKR3 Axis in the Tumor Microenvironment: Signaling, Crosstalk, and Therapeutic Targeting
Martine J Smit1, Géraldine Schlecht-Louf2, Maria Neves2,3,4,5
1Department of Medicinal Chemistry, Amsterdam Institute of Molecular and Life Sciences (AIMMS), Faculty of Science, Vrije Universiteit Amsterdam, 1081 HZ Amsterdam, Netherlands;
Abstract:
Elevated expression of the chemokine receptors CXCR4 and ACKR3 and of their cognate ligand CXCL12 is detected in a wide range of tumors and the tumor microenvironment (TME). Yet, the molecular mechanisms by which the CXCL12/CXCR4/ACKR3 axis contributes to the pathogenesis are complex and not fully understood. To dissect the role of this axis in cancer, we discuss its ability to impinge on canonical and less conventional signaling networks in different cancer cell types; its bidirectional crosstalk, notably with receptor tyrosine kinase (RTK) and other factors present in the TME; and the infiltration of immune cells that supporttumor progression. We discuss current and emerging avenues that target the CXCL12/CXCR4/ACKR3 axis. Coordinately targeting both RTKs and CXCR4/ACKR3 and/or CXCL12 is an attractive approach to consider in multitargeted cancer therapies. In addition, inhibiting infiltrating immune cells or reactivating the immune system along with modulating the CXCL12/CXCR4/ACKR3 axis in the TME has therapeutic promise.
Insights
The CXCL12/CXCR4/ACKR3 axis drives cancer through complex signaling and immune cell interactions. Targeting this axis, alongside receptor tyrosine kinases or immune cells, offers promising therapeutic strategies for cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- The chemokine pathway involving CXCL12, CXCR4, and ACKR3 is upregulated in various tumors and the tumor microenvironment (TME).
- The precise mechanisms by which this axis influences cancer pathogenesis remain incompletely understood.
- This axis plays a role in tumor progression through intricate signaling networks and immune cell modulation.
Purpose of the Study:
- To elucidate the multifaceted roles of the CXCL12/CXCR4/ACKR3 axis in cancer development.
- To explore the axis's interactions with signaling pathways and the TME.
- To review current and novel therapeutic strategies targeting this axis.
Main Methods:
- Review of existing literature on the CXCL12/CXCR4/ACKR3 axis in cancer.
- Analysis of molecular mechanisms, including canonical and non-canonical signaling.
- Examination of crosstalk with receptor tyrosine kinases (RTKs) and immune cells within the TME.
Main Results:
- The CXCL12/CXCR4/ACKR3 axis impacts diverse cancer cell signaling pathways.
- Bidirectional crosstalk exists between this axis, RTKs, and other TME components.
- The axis influences immune cell infiltration, which can promote tumor progression.
Conclusions:
- Targeting the CXCL12/CXCR4/ACKR3 axis is a key strategy in cancer therapy.
- Combined targeting of RTKs and the CXCL12/CXCR4/ACKR3 axis presents a viable multitargeted approach.
- Modulating this axis in conjunction with immune cell inhibition or activation holds significant therapeutic potential.
Related Concept Videos
The Tumor Microenvironment
The JAK-STAT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Intracellular Signaling Affects Focal Adhesions
Some...
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways

